Number of the records: 1
Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A Perspective
Title Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A Perspective Author Baka T. Co-authors Repova Bednarova Kristina Ľupták Ivan Šimko Fedor SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV ORCID Source document Current Pharmaceutical Design. Vol. 28, no. 19 (2022), p. 1581 - 1588 Language eng - English Country NL - Netherlands Document kind rozpis článkov z periodík (rbx) Citations DELGADO-BETANCOURT, V. - CHINDA, K. - MESIRCA, P. - BARRèRE, C. - COVINHES, A. - GALLOT, L. - VINCENT, A. - BIDAUD, I. - KUMPHUNE, S. - NARGEOT, J. - PIOT, C. - WICKMAN, K. - MANGONI, M.E. - BARRèRE-LEMAIRE, S. Heart rate reduction after genetic ablation of L-type Casubv/sub1.3 channels induces cardioprotection against ischemia-reperfusion injury. In FRONTIERS IN CARDIOVASCULAR MEDICINE. ISSN 2297-055X, AUG 1 2023, vol. 10. Dostupné na: https://doi.org/10.3389/fcvm.2023.1134503. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.2174/1381612828666220328114236 article
File name Access Size Downloaded Type License Ivabradine in the Management of COVID-19-related Cardiovascular Complications.pdf available 1.9 MB 1 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 3.310 Q3 0.571 Q2
Number of the records: 1